Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison Between Celox Versus Bakri Balloon for Treatment of Primary Atonic Postpartum Hemorrhage
Brief Summary: Postpartum hemorrhage (PPH) is responsible for around 25% of maternal mortality worldwide reaching as high as 60% in some countries.

Postpartum hemorrhage is defined as loss of 500 mL or more in a vaginal delivery and 1 Litre or more in a cesarean delivery.Also any blood loss that cause hemodynamic instability should be considered a PPH.

In 2012, WHO updated the guidelines for the management of PPH and retained placenta to include: "The use of intrauterine balloon tamponade is recommended for the treatment of PPH due to uterine atony. This recommendation is now stronger than the previous guidelines. It can be used for women who do not respond to uterotonics or if uterotonics are not available. This procedure potentially can avoid surgery and is appropriate while awaiting transfer to a higher-level facility".Furthermore, FIGO included Uterine balloon tamponade as a recommended second-line intervention for the treatment of PPH in their updated guidelines issued in 2012.

In 2006, the ACOG Practice Bulletin, published by the American College of Obstetricians and Gynecologists, made mention of the Bakri postpartum balloon for its specifically tailored design that enables conservative management of uterine bleeding in cases of uterine atony and other causes of PPH.

The reports demonstrated that balloon tamponade is helpful in managing PPH secondary to a wide variety of causes in resource-poor settings.

One of the new methods that could be used to control PPH is Uterine packing with chitosan-covered gauze or Celox.

Celox Haemostats are dressings with natural material called chitosan to control major haemorrhage including life-threatening bleeding . They are simple and effective, stopping major bleeding.It was first used by military forces to stop sever bleeding in the scene with no other options to stop bleeding. Celox™ granules are actually very high surface area flakes. When they come in contact with blood, Celox™ swells, gels, and sticks together to make a gel like clot, without generating any heat. Celox™ does not set off the normal clotting cascade, it only clots the blood it comes directly into contact with. Celox works on casualties using anticoagulants and anti-platelet therapy such as aspirin .


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: OTHER; Interventions: Device: non-pneumatic anti-shock garment | Intervention Type: DEVICE; Name: non-pneumatic anti-shock garment; Assigned to Arm(s): Intervention
B: Arm Label: B-Lynch; Type: ACTIVE_COMPARATOR; Interventions: Procedure: B-Lynch | Arm Label: Bakri balloon; Type: ACTIVE_COMPARATOR; Interventions: Procedure: BALLOON INSERTION | Intervention Type: PROCEDURE; Name: B-Lynch; Assigned to Arm(s): B-Lynch | Intervention Type: PROCEDURE; Name: BALLOON INSERTION; Assigned to Arm(s): Bakri balloon
C: Arm Label: stepwise uterine devascularization; Type: ACTIVE_COMPARATOR; Interventions: Procedure: stepwise uterine devascularization | Arm Label: A glove-loaded Foley's catheter; Type: EXPERIMENTAL; Interventions: Procedure: A glove-loaded Foley's catheter tamponade | Intervention Type: PROCEDURE; Name: A glove-loaded Foley's catheter tamponade; Assigned to Arm(s): A glove-loaded Foley's catheter | Intervention Type: PROCEDURE; Name: stepwise uterine devascularization; Assigned to Arm(s): stepwise uterine devascularization
D: Arm Label: Celox group; Type: ACTIVE_COMPARATOR; Interventions: Device: Celox group | Arm Label: Bakri balloon group; Type: ACTIVE_COMPARATOR; Interventions: Device: Bakri Balloon | Intervention Type: DEVICE; Name: Celox group; Assigned to Arm(s): Celox group | Intervention Type: DEVICE; Name: Bakri Balloon; Assigned to Arm(s): Bakri balloon group

Answer: D